italian HIV AIDS vaccine English HIV AIDS vaccine
HIV AIDS TAT Vaccines logo image
 
  HOME
 
  HIV and AIDS
    What is "AIDS"
    Routes of infection
    First symptoms
    Having AIDS
    Can AIDS be cured?
   
  The Need for Vaccines
    AIDS in the World
    AIDS in Africa
   
  HIV-1 Tat:
  A NOVEL APPROACH TO VACCINATION
    Scientific Background & Rationale
    HIV-1 Tat Protein
    Pre-clinical Studies
    Clinical Studies
    International Collaborations
 
  TAT VACCINE CANDIDATES
 
    1st. Gen.: Tat alone
    2nd Gen.: Tat+Microparticles
    2nd Gen.: Tat+Env
    Discovery Phase Leads
  MANUFACTURING
  CLINICAL TRIAL PLANS
  INTELLECTUAL PROPERTY
  NEWS
 
 
 
  T-002: Independent Advisory Boards
ISS T-002: SECTION INDEX
International Advisory Board
An International Advisory Board ("IAB") - composed of 7 international experts in the immunological, virological or vaccine field. The IAB provides independent advice to the Sponsor in taking decisions, alternative strategies and solutions in any critical situations that may ensue from the study.
Jay A. Levy, MD
Professor, Department of Medicine, Division Hematology. Director of the Laboratory for Tumor and AIDS Virus Research, University of California, School of Medicine San Francisco.
Gian Vincenzo Zuccotti, MD
Associate Professor, "Università degli Studi di Milano", Children's Hospital Director "AO Luigi Sacco", Milan, Italy.
Lorenzo Moretta, MD
Scientific Director, Children's Hospital "G. Gaslini", Genova. Professor, Department of General Pathology and Physiopathology of the "Università di Genova", Genova, Italy.
Saladin Osmanov, Dr
World Health Organization (WHO) and UNAIDS Coordinator, Geneva. WHO Coordinator for the HIV Vaccine Initiative, Geneva, Switzerland.
Jan Holmgren, Ph.D.
Professor of Medical Microbiology and Immunology at Goteborg University; Director of the Goteborg University Vaccine Research Institute (GUVAX), Sweden. Specialist for mucosal vaccine against cholera.
Carlos Alberto Guzman, Ph.D.
Scientific Director, Department of Vaccinology, Helmholtzt Centre for Infection Research, Braunschweig, Germany. Professor of Medical Microbiology, MHH Hannover Medical School, Hannover, Germany. Vaccine, immunomodulator, delivery system for DNA vaccines and gene therapy expert.
Frank Goebel, M.D.
Professor, Department of Infectious Diseases and Tropical Medicine, University of Munich, Germany.
Antonio Cassone, M.D., Ph.D
Expert for anti-fungal and anti-influenza vaccine activities, Istituto Superiore di Sanità, Rome, Italy.
Data Safety Monitoring Board
A Data Safety Monitoring Board ("DSMB") - formed by international experts of well-documented experience in the field of HIV/AIDS. The DSMB will monitor the safety of the vaccine by periodically evaluating all data during the trial.
Dr. Patrizia Popoli
Research Director, Department of Drug Research and Evaluation; Pharmacovigilance and Neuropharmacology Expert, Istituto Superiore di Sanità, Rome, Italy.
Dr. Francesca Menniti Ippolito
Researcher, National Centre for epidemiology, surveillance and health; Epidemiologist and Biostatistician for Clinical Epidemiology, Infectious Diseases and Pharmacoepidemiology, Istituto Superiore di Sanità, Rome, Italy.
Prof. Veronica Miller
Professor, George Washinghton University, USA; Director of the "Forum for collaborative HIV Research"; Co- Founder and coordinator of the EuroGuidelines for the standardization between countries for public health management. Advisor for several companies and institutional committees, such as "FDA Antiviral Advisory Committee".
Dr. Josè Maria Mirò
Reasearcher, Hospital Clinic - IDIBAPS. University of Barcelona. Barcelona (Spain). Expert on infectious diseases and in the clinical and therapeutic management of HIV infection.
Community Advisory Board
A Community Advisory Board ("CAB") - constituted by representative of patients or communities hit by HIV. The CAB will assist the Sponsor in supporting the interests and well being of the patients.
R. Biondi
NADIR Onlus - HIV Treatment Group.
V. Cantarella
GITA - Gruppo Italiano Terapie Anti-HIV.
M. Formisano
NPS - Network Persone Sieropositive.
A. Poto
ARCIGAY
 

 

ITALIAN SUPPORTING
INSTITUTIONS
 
   
  NATIONAL AIDS CENTER  
       
  NATIONAL INSTITUTE OF HEALTH  
       
  MINISTRY OF HEALTH  
       
  MINISTRY OF FOREIGN AFFAIRS  
       
  SAN GALLICANO HOSPITAL  
       
  UNIVERSITY OF URBINO  
       
       
   
 
   
      Government agencies  
       
      Patients  
       
      Scientists  
       
      Professionals  
       
      Industry  
       
      Basic scientific dictionary  
       
      Faqs  
       
  SCIENTIFIC PUBLICATIONS  
       
  USEFUL LINKS  
       
  CONTACT US